Table 4 All-cause annual healthcare-related cost and pharmacy-related cost in patients with rheumatoid arthritis diagnosis by year
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|
Average all-cause annual healthcare-related cost | ||||||
Cost for all patients in USD PPP | ||||||
Consultation’s cost | $ 25,142,401 | $ 16,732,917 | $ 22,467,111 | $ 36,744,756 | $ 36,391,280 | $ 23,031,841 |
Hospital admission cost * | $ 468,975 | $ 603,419 | $ 561,457 | $ 527,825 | $ 403,622 | $ 354,403 |
Procedures cost ** | $ 2,860,200 | $ 6,750,821 | $ 5,562,834 | $ 11,490,856 | $ 5,266,869 | $ 6,356,080 |
Imaging procedures *** | $ 268,268 | $ 696,295 | $ 333,560 | $ 306,268 | $ 360,065 | $ 315,420 |
Laboratories **** | $ 68,896 | $ 694,942 | $ 205,336 | $ 183,396 | $ 211,448 | $ 213,861 |
Cost per patient in USD PPP | ||||||
Consultation cost | $ 266 | $ 155 | $ 163 | $ 310 | $ 262 | $ 183 |
Hospital admission cost * | $ 566 | $ 549 | $ 440 | $ 629 | $ 364 | $ 282 |
Procedures cost** | $30 | $63 | $40 | $97 | $38 | $ 51 |
Imaging procedures *** | $3 | $6 | $2 | $3 | $3 | $3 |
Laboratories **** | $1 | $6 | $1 | $2 | $2 | $2 |
Cost USD PPP all patients | $ 28,471,575 | $ 24,087,158 | $ 28,591,402 | $ 48,763,437 | $ 42,061,770 | $ 29,742,324 |
Cost USD PPP per patient | $ 301 | $ 224 | $ 208 | $ 412 | $ 303 | $ 237 |
Pharmacy-related cost | ||||||
Cost in USD PPP | ||||||
csDMARDs | $ 14,922,141 | $ 19,642,704 | $ 10,067,161 | $ 13,259,536 | $ 18,031,917 | - |
bDMARDs | $ 62,966,462 | $ 59,518,949 | $ 78,743,927 | $ 56,044,637 | $ 52,710,269 | - |
tsDMARDs | $ 562,121,936 | $ 909,584,806 | $ 783,945,643 | $ 586,423,485 | $ 456,959,438 | - |
Steroids | $ 299,627 | $ 145,992 | $ 281,198 | $ 228,523 | $ 435,472 | - |
Costs in USD PPP all patients | $ 640,310,165 | $ 988,892,450 | $ 873,037,929 | $ 655,956,180 | $ 528,137,096 | - |
Costs in USD PPP per patient | $6,777 | $9,179 | $6,350 | $5,539 | $3,805 | - |